Andrew Partheniou


Recent Articles

Biotech Co. Makes Strides on Three Fronts 09/19/2023

This Canadian firm sold assets, launched an equity raise and filed a clinical trial application for its lead psychedelic-assisted psychotherapy program, noted a Stifel report.

Recent Quotes

"AWKN announced its first KARE licensing agreement."

— Andrew Partheniou, Stifel (8/15/22)
more >

"AWKNF shares offer an attractive risk-reward profile."

— Andrew Partheniou, Stifel (3/31/22)
more >

Due to permission requirements, not all quotes are shown.